QVT Financial
Venture Capital
Active
New York, United States
25
56M
20
1.19
3
0.20
14
- Stages of investment
- Areas of investment
Summary
QVT Financial appeared to be the VC, which was created in 2003. The venture was found in North America in United States. The main department of described VC is located in the New York.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the QVT Financial, startups are often financed by Sofinnova Partners, Gimv, Auriga Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, Three Arch Partners, Foresite Capital. In the next rounds fund is usually obtained by Flagship Pioneering, Viking Global Investors, Three Arch Partners.
We also calculated 3 valuable employees in our database.
The average startup value when the investment from QVT Financial is more than 1 billion dollars. The high activity for fund was in 2014. The higher amount of exits for fund were in 2015. The usual things for fund are deals in the range of 50 - 100 millions dollars. The real fund results show that this VC is 14 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this QVT Financial works on 40 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AveXis, Roivant Sciences, Adaptimmune. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Broadcasting, Content.
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 25
- Lead investments
- 3
- Exits
- 14
- Rounds per year
- 1.19
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (20)
- Health Care (10)
- Biopharma (8)
- Therapeutics (7)
- Medical (7) Show 23 more
- Investments by region
-
- United States (19)
- United Kingdom (2)
- Canada (1)
- France (1)
- Israel (1)
- Peak activity year
- 2006
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 352M
- Group Appearance index
- 0.92
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.02
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Acceleron Pharma | 01 Oct 2007 | Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical | Late Stage Venture | 31M | United States, Massachusetts, Cambridge |
Active Surfaces | 13 May 2024 | Renewable Energy, Solar | Seed | 5M | United States, Massachusetts, Salem |
AITREAT | 01 Oct 2016 | Robotics, Medical Device, Medical | Seed | 200K | Central, Singapore, Singapore |
1Huddle | 15 Mar 2017 | Educational Software, Educational and Training Services (B2C), Social/Platform Software, Human Resources, SaaS, Enterprise Software, Training, Gamification | Seed | 500K | United States, New York |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.